About Daffodills
Daffodills is a Healthcare company based in Meerut (India) founded in 1996. It manufactures and exports high-quality pharmaceutical formulations for domestic and international markets. It operates on a B2B model. The company has 11 employees. Its Indian entity Daffodills Pharmaceuticals Limited reported revenue of ₹30.18 Cr. Daffodills offers products and services including Finished Dosage Forms. Its focus areas include Pharmaceuticals, Drug Manufacturing and Formulations. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Daffodills Pharmaceuticals is a company that develops and markets innovative pharmaceutical formulations, focusing on improving human life through quality products at affordable prices. Based in Meerut, India, it operates as a manufacturer and exporter serving both domestic and international markets. The company emphasizes total quality in its production processes and has established trust among medical professionals and end users worldwide. Its activities include exporting finished dosage forms and maintaining high standards in manufacturing.
- Headquarters Meerut, India
- Employees 11
- SectorsHealthcare
- Email••••••••
- Website daffodills.in
- Legal Name Daffodills Pharmaceuticals Limited
- Date of Incorporation 28 May, 1985
- Jurisdiction Meerut, Uttar Pradesh, India
- Annual Revenue₹30.18 Cr
FY 2023 · +32% YoY
- Net Profit₹52.2 Lakh
FY 2023 · 2% margin
- EBITDA₹80.3 Lakh
FY 2023 · 3% margin
- Employee Count11
Associated legal entities of Daffodills
Daffodills operates through Daffodills Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daffodills Pharmaceuticals Limited CIN U24233UP1985PLC007205 | Active | 28 May 1985 | Meerut, Uttar Pradesh | ₹30.2 Cr | 11 | 5 | View details |
Products & Services of Daffodills
Daffodills offers a comprehensive portfolio of products and services, including Finished Dosage Forms.
Manufactured pharmaceutical formulations for medical treatment and export
Board of directors of Daffodills Pharmaceuticals Limited (Daffodills)
Daffodills Pharmaceuticals Limited is the primary company behind Daffodills. The board of Daffodills Pharmaceuticals Limited currently have 5 directors; the longest-serving is Pranav Chaudhary, appointed in 2012. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pranav Chaudhary DIN 05206672 | Director | 22 Feb 2012 | 14 yrs 7 mo | Daffodills Pharmaceuticals Limited |
| Prateek Chaudhary DIN 05206692 | Director | 22 Feb 2012 | 14 yrs 7 mo | Daffodills Pharmaceuticals Limited |
| Prashant Chaudhry DIN 05299350 | Director | 02 Aug 2018 | 8 yrs 2 mo | Daffodills Pharmaceuticals Limited |
| Prabhat Kumar Rai DIN 08346786 | Whole-time director | 30 Jul 2019 | 7 yrs 2 mo | Daffodills Pharmaceuticals Limited |
| Kunwar Krishanpal Singh DIN 08346855 | Whole-time director | 30 Jul 2019 | 7 yrs 2 mo | Daffodills Pharmaceuticals Limited |
Financials of Daffodills
Figures of Daffodills Pharmaceuticals Limited, the primary company behind Daffodills, for FY 2023. Revenue was ₹30.18 Cr (+32% year on year). Net profit was ₹52.2 Lakh (2% margin). EBITDA was ₹80.3 Lakh (3% margin). Revenue has grown at a compounded annual rate of -8% over three years and -1% over five years.
- ₹30.18 CrRevenue · FY 2023 · +32% YoY
- ₹52.2 LakhNet profit · 2% margin
- ₹80.3 LakhEBITDA · 3% margin
- ₹3.23 CrPaid-up capital
- 11Employees (provident fund records)
- -8%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daffodills Pharmaceuticals Limited are on its company page.
Detailed financial statements for Daffodills
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Daffodills
Daffodills has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Daffodills
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Daffodills (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Daffodills
Daffodills was founded in 1996.
Daffodills is headquartered in Meerut, India. It is registered at Meerut, Uttar Pradesh, India.
Daffodills has 11 employees.
The primary company behind Daffodills, Daffodills Pharmaceuticals Limited, reported revenue of ₹30.18 Cr for FY 2023, up 32% year on year.
Daffodills Pharmaceuticals is a company that develops and markets innovative pharmaceutical formulations, focusing on improving human life through quality products at affordable prices. Based in Meerut, India, it operates as a manufacturer and exporter serving both domestic and international markets. The company emphasizes total quality in its production processes and has established trust among medical professionals and end users worldwide. Its activities include exporting finished dosage forms and maintaining high standards in manufacturing.
Daffodills's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Daffodills offers Finished Dosage Forms.
Daffodills operates through Daffodills Pharmaceuticals Limited.
The legal entities of Daffodills currently have 5 directors, including Pranav Chaudhary, Prateek Chaudhary, Prabhat Kumar Rai and others.